Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Jan 27, 2021; 13(1): 19-29
Published online Jan 27, 2021. doi: 10.4240/wjgs.v13.i1.19
Table 3 Perioperative characteristics in the obese group (body mass index 30 kg/m²)
LH vs OH
LH cohort (n = 27)
OH cohort (n = 29)
P value
Operative data
Operative time (min)194 ± 81260 ± 1370.009
Major resection, n (%)5 (18.5)5 (17.2)0.901
Operative procedure, n (%)0.257
Atypical7 (25.9)8 (27.6)
Segmentectomy4 (14.8)7 (24.1)
Bisegmentectomy11 (40.7)9 (31.0)
Left hepatectomy0 (0.0)3 (10.3)
Right hepatectomy5 (18.5)2 (6.9)
Conversion2 (7.4)-
Postoperative data
Intensive care/d0.7 ± 0.41.0 ± 0.80.240
Hospitalization/d7.7 ± 4.317.2 ± 17< 0.001
Blood transfusion3 (11.1)8 (27.6)0.121
Hospital mortality, n (%)0 (0.0)0 (0.0)0.080
Postoperative complications, n (%)0.562
No complications19 (70.4)17 (58.6)
Clavien-Dindo I3 (11.1)2 (6.9)
Clavien-Dindo II1 (3.7)2 (6.9)
Clavien-Dindo IIIa3 (11.1)3 (10.3)
Clavien-Dindo IIIb1 (3.7)2 (6.9)
Clavien-Dindo IVa0 (0.0)3 (10.3)
Clavien-Dindo IVb0 (0.0)0 (0.0)
Clavien-Dindo V0 (0.0)0 (0.0)
Clavien ≥ IIIb1 (3.7)5 (17.2)0.102
Clavien ≥ I8 (29.6)12 (41.4)0.359
Biliary leakage1 (3.7)3 (10.3)0.335
Liver failure0 (0.0)2 (6.9)0.165
Surgical site infections2 (7.4)4 (13.8)0.440
Pneumonia0 (0.0)0 (0.0)-
CCI5.4 ± 11.112.3 ± 16.80.132
Estimated cost (€)10111 ± 1748 11021 ± 31330.710